Clinical Trial Update: Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of pemetrexed chemotherapy in poor-risk patients with advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-10